Panitumumab in combination with modified docetaxel/ cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group
Keyword(s):
Phase Ii
◽
2013 ◽
Vol 71
(6)
◽
pp. 1445-1451
◽
Keyword(s):
2009 ◽
Vol 72
(1)
◽
pp. S35
◽